PTEN和FHIT基因与卵巢癌关系的研究进展(4)
\[16\]Wu H,Wang S,Weng D,et al.Reversal of the m alignant phenotype of ovarian cancer A2780 cells through transfection with wild-type PTEN gene\[J\].Cancer Lett,2008,271(2):205-214.
\[17\]Takei Y,Saga Y,Mizukami H,et al.Overexpression of PTEN in ovarian cancer cells suppresses i.p. dissemination and extends survival in mice\[J\].Mol Cancer Ther,2008,7(3):704-711.
\[18\]Hong FZ,Wang B,Li HM,et al.Hypermethylation of fragile histidine triad gene and 3p14 allelic deletion in ovarian carcinomas\[J\]. Zhonghua Bing Li Xue Za Zhi,2005,34(5):257-261.
\[19\]Manderson EN,Presneau N,Provencher D,et a1.Comparative analysis of loss of heterozygosity of specific chromosome 3,13,17,and X loci and Tp53 mutations in human epithelial ovarian cancer\[J\].Mol Carcinog,2002,34(2):78-90.
\[20\]Dhillon VS,Shahid M, Husain SA.CpG methylation of the FHIT, FANCF, cyclin-D2, BRCA2 and RUNX3 genes in Granulosa cell tumors(GCTS) of ovarian origin\[J\].Mol Cancer,2004,3:33.
\[21\]Mandai M,Konishi I,Kuroda H,et a1.Expresion of abnormal transcripts of the FHIT(fragile histidine triad)gene in ovarian carcinoma\[J\].Eur J Cancer,1998,34(5):745-749.
\[22\]Ozaki K,Enomoto T,Yoshino K,et a1.Impaired Fhit expresion characterizes serous ovarian carcinoma\[J\].Br J Cancer,2001,85(2):247-254.(收稿日期:2009-04-26), 百拇医药(黄 建 陈 衡)
\[17\]Takei Y,Saga Y,Mizukami H,et al.Overexpression of PTEN in ovarian cancer cells suppresses i.p. dissemination and extends survival in mice\[J\].Mol Cancer Ther,2008,7(3):704-711.
\[18\]Hong FZ,Wang B,Li HM,et al.Hypermethylation of fragile histidine triad gene and 3p14 allelic deletion in ovarian carcinomas\[J\]. Zhonghua Bing Li Xue Za Zhi,2005,34(5):257-261.
\[19\]Manderson EN,Presneau N,Provencher D,et a1.Comparative analysis of loss of heterozygosity of specific chromosome 3,13,17,and X loci and Tp53 mutations in human epithelial ovarian cancer\[J\].Mol Carcinog,2002,34(2):78-90.
\[20\]Dhillon VS,Shahid M, Husain SA.CpG methylation of the FHIT, FANCF, cyclin-D2, BRCA2 and RUNX3 genes in Granulosa cell tumors(GCTS) of ovarian origin\[J\].Mol Cancer,2004,3:33.
\[21\]Mandai M,Konishi I,Kuroda H,et a1.Expresion of abnormal transcripts of the FHIT(fragile histidine triad)gene in ovarian carcinoma\[J\].Eur J Cancer,1998,34(5):745-749.
\[22\]Ozaki K,Enomoto T,Yoshino K,et a1.Impaired Fhit expresion characterizes serous ovarian carcinoma\[J\].Br J Cancer,2001,85(2):247-254.(收稿日期:2009-04-26), 百拇医药(黄 建 陈 衡)